Advertisement

Electrolyte Disorders in Pregnancy

  • Valerie BartaEmail author
  • Holly Koncicki
Chapter

Abstract

In pregnancy, central nervous system and hormonal changes lead to altered regulation of salt and water. This chapter discusses the differential diagnosis for hyponatremia and hypernatremia during pregnancy and the management in the pregnant woman.

Keywords

Electrolyte disorders in pregnancy Pregnancy and electrolyte disorders Hyponatremia in pregnancy Salt and water balance in the pregnant patient Syndrome of inappropriate antidiuretic hormone in pregnancy Hypoosmolar hyponatremia in pregnancy 

References

  1. 1.
    Brunton PJ, Arunachalam S, Russel JA. Control of neurohypophysial hormone secretion, blood osmolality and volume in pregnancy. J Physiol Pharmacol. 2008;59(Suppl 8):27–45.PubMedGoogle Scholar
  2. 2.
    Pazhayattil GS, Rastegar A, Brewster UC. Approach to the diagnosis and treatment of hyponatremia in pregnancy. Am J Kidney Dis. 2015;65(4):623–7.  https://doi.org/10.1053/j.ajkd.2014.09.027. Epub 2014 Dec 24.CrossRefPubMedGoogle Scholar
  3. 3.
    Joo KW, et al. Antiduiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2. Nephrol Dial Transplant. 2004;19:2480–6.  https://doi.org/10.1093/ndt/gfh413. Advance Access publication 27 July 2004.CrossRefPubMedGoogle Scholar
  4. 4.
    Knight S, Snellen H, Humphreys M, Baylis C. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. Am J Physiol Renal Physiol. 2007;292:F655–9.CrossRefGoogle Scholar
  5. 5.
    Harris K, Shankar R, Black K, Rochelson B. Reset osmostat in pregnancy: a case report. J Matern Fetal Neonatal Med. 2014;27(5):530–3.  https://doi.org/10.3109/14767058.2013.819333. Epub 2013 July 23.CrossRefPubMedGoogle Scholar
  6. 6.
    Mathot M, Maton P, Henrion E, François-Adant A, Marguglio A, Gaillez S, et al. Pseudo-Bartter syndrome in a pregnant mother and her fetus. Pediatr Nephrol. 2006;21(7):1037–40. Epub 2006 May 30.CrossRefGoogle Scholar
  7. 7.
    Irani M, Fisher N, Mor A, Bensinger G. Urinary retention and syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to impacted gravid uterus. J Obstet Gynaecol Res. 2016;42(6):734–7.  https://doi.org/10.1111/jog.12963. Epub ahead of print.CrossRefPubMedGoogle Scholar
  8. 8.
    Bodenmann PG, et al. Preeclampsia and electrolyte disturbances in a case report. Nephrol Ther. 2014;10(1):51–7.CrossRefGoogle Scholar
  9. 9.
    Sandhu G, Ramaiah S, Chan G, Meisels I. Pathophysiology and management of pre-eclampsia-associated severe hyponatremia. Am J Kidney Dis. 2010;55(3):599–603.CrossRefGoogle Scholar
  10. 10.
    Sutton RA, Schonholzer K, Kassen BO. Transient syndrome of inappropriate antidiuretic hormone secretion during pregnancy. Am J Kidney Dis. 1993;21:444–5.CrossRefGoogle Scholar
  11. 11.
    Roberts TJ, Nijland MJM, Williams L, Ross MG. Fetal diuretic responses to maternal hyponatremia; contribution of placental sodium gradient. J Appl Physiol. 1999;87(4):1440–7.CrossRefGoogle Scholar
  12. 12.
    Chapman T, Hamilton M. Water intoxication presenting as maternal and neonatal seizures: a case report. J Med Case Rep. 2008;2(1):366.CrossRefGoogle Scholar
  13. 13.
    Basu A, Dillon RDS, Taylor R, Davison JM, Marshall SM. Is normalization of serum potassium and magnesium always necessary in Gitelman Syndrome for a successful obstetric outcome? BJOG Int J Obstet Gynecol. 2004;111:630–4.CrossRefGoogle Scholar
  14. 14.
    Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013;20(3):209–14.CrossRefGoogle Scholar
  15. 15.
    Gunganah K, Carpenter R, Drake WM. Eplerenone use in primary aldosteronism during pregnancy. Clinical case reports. London: Department of Endocrinology, St. Bartholomew’s Hospital. Accepted 25 July 2015.Google Scholar
  16. 16.
    Kellerman E. Renal control of electrolytes and acid-base balance during pregnancy. In: Alvarez RR, editor. Kidney in pregnancy, clinical monographs in obstetrics and gynecology. New York: Wiley; 1976. p. 85–96.Google Scholar
  17. 17.
    Landau E, Amar L. Primary aldosteronism and pregnancy. Ann Endocrinol (Paris). 2016;77(2):148–60.CrossRefGoogle Scholar
  18. 18.
    Kosaka KN, Onada T, Ishikawa N, Iwanaga J, Yamamasu, Tahara H, et al. Laparascopic adrenalectomy on a patient with primary aldosteronism during pregnancy. Endocrinol J. 2006;53:461–6.Google Scholar
  19. 19.
    Ada ED, et al. Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. NEJM. 2015;373:1429–36.CrossRefGoogle Scholar
  20. 20.
    Riester A, Reincke M. Progress in primary aldosteronism review. Mineralocorticoid receptor antagonists and management of primary aldosteronism in pregnancy. Eur J Endocrinol. 2015;172:R23–30. Munich, Germany.CrossRefGoogle Scholar
  21. 21.
    Srisuttayasathien M. Hypokalemia induced rhabdomyolysis as a result of distal renal tubular acidosis in a pregnant woman: a case report and literature review. Case Rep Obstet Gynecol. 2015:947617. Department of Obstetrics and Gynecology, Chaophraya Yommaraj Hospital, Thailand. 2015. Hindawi Publishing Corporation.Google Scholar
  22. 22.
    Muthukrishnan J, Harikumar KVS, Ratan J, Kirtikumar M. Pregnancy predisposes to rhabdomyolysis due to hypokalemia. Saudi J Kidney Dis Transpl. 2010;21(6):1127–8. Department of Endocrinology, Medwin Hospital, Hyderabad, India.PubMedGoogle Scholar
  23. 23.
    Kulkarni M, Srividya TV, Gopal N. Hypokalemia paraplegia in pregnancy. J Clin Diagn Res. 2014;8(6):OD03–4.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Santra G, Paul R, Das S, Pradhan S. Hyperventilation of pregnancy presenting with flaccid quadriparesis due to hypokalemia secondary to respiratory alkalosis. J Assoc Physicians India. 2014;62(6):536–8.PubMedGoogle Scholar
  25. 25.
    Caretto A, Primerano L, Novara F, Zuffardi O, Genovese S, Rondinelli M. A therapeutic challenge: Liddle’s syndrome managed with amiloride during pregnancy. Case Rep Obstet Gynecol. 2014;2014:156250. Hindawi Publishing Corporation.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Ribeiro RBF, da Silveira Junior SAD, Silva CCB, Gontijo GR. Gitelman syndrome: from diagnosis to follow-up during pregnancy. Braz J Nephrol. 2015;37(2). Sau Paulo.Google Scholar
  27. 27.
    Iheonunekwu NC, Ibrahim TM, Davies D, Pickering K. Thyrotoxic hypokalemic paralysis in a pregnant Afro-Caribbean woman. A case report and review of the literature. West Indian Med J. 2004;53(1):47–9.PubMedGoogle Scholar
  28. 28.
    Myopathy MKD. Hypokalemia and Pica (geophagia) in pregnancy. Ulster Med J. 2006;75(2):159–60.Google Scholar
  29. 29.
    Dalton LM, Ní Fhloinn DM, Gaydadzhieva GT, Mazurkiewicz OM, Leeson H, Wright CP. Magnesium in pregnancy. Nutr Rev. 2016;74(9):549–57.  https://doi.org/10.1093/nutrit/nuw018. Epub 2016 Jul 21. https://www.ncbi.nlm.nih.gov/pubmed/27445320.CrossRefPubMedGoogle Scholar
  30. 30.
    Beloosesky R, Khatib N, Ginsberg Y, et al. Maternal magnesium sulfate fetal neuroprotective effects to the fetus: inhibition of neuronal nitric oxide synthase and nuclear factor kappa-light-chain-enhancer of activated B cells activation in a rodent model. Am J Obstet Gynecol. 2016;215(3):382.e1–6.  https://doi.org/10.1016/j.ajog.2016.03.032. Epub 2016 Mar 24. https://www.ncbi.nlm.nih.gov/pubmed/27018467.CrossRefGoogle Scholar
  31. 31.
    Crowther CA, Hiller JE, Doyle LW, Haslam RR, Australasian Collaborative Trial of Magnesium Sulfate Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized control trial. JAMA. 2003;290:2669–76.CrossRefGoogle Scholar
  32. 32.
    Marret S, Marpeau L, Zupan-Simunek V, PREMAG Trial Group, et al. Magnesium sulfate given before very preterm birth to protect infant brain: the randomized controlled PREMAG trial. BJOG. 2007;114:310–8.CrossRefGoogle Scholar
  33. 33.
    Rouse DJ, Hirtz DG, Thorn E, et al. A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy. NEJM. 2009;359:895–905.CrossRefGoogle Scholar
  34. 34.
    Abad C, Vargas FR, Zoltan T, Proverbio T, Piñero S, Proverbio F, Marín R. Magnesium sulfate affords protection against oxidative damage during severe preeclampsia. Placenta. 2015;36(2):179–85.  https://doi.org/10.1016/j.placenta.2014.11.008. Epub 2014 Nov 25. https://www.ncbi.nlm.nih.gov/pubmed/25486968.CrossRefPubMedGoogle Scholar
  35. 35.
    Jafrin W, Mia AR, Chakraborty PK, Hoque MR, Paul UK, Shaha KR, Akhter S, Roy AS. An evaluation of serum magnesium status in pre-eclampsia compared to the normal pregnancy. Mymensingh Med J. 2014;23(4):649–53. https://www.ncbi.nlm.nih.gov/pubmed/25481580.PubMedGoogle Scholar
  36. 36.
    de Sousa Rocha V, Della Rosa FB, Ruano R, Zugaib M, Colli C. Association between magnesium status, oxidative stress and inflammation in preeclampsia: a case-control study. Clin Nutr. 2015;34(6):1166–71.  https://doi.org/10.1016/j.clnu.2014.12.001. Epub 2014 Dec 5. https://www.ncbi.nlm.nih.gov/pubmed/25559945.CrossRefPubMedGoogle Scholar
  37. 37.
    Udenze IC, Arikawe AP, Azinge EC, Okusanya BO, Ebuehi OA. Calcium and magnesium metabolism in pre-eclampsia. West Afr J Med. 2014;33(3):178–82. https://www.ncbi.nlm.nih.gov/pubmed/26070821.PubMedGoogle Scholar
  38. 38.
    Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Asp Med. 2003;24:107–36.CrossRefGoogle Scholar
  39. 39.
    Spinnato JA, Livingston JC. Prevention of preeclampsia with antioxidants: evidence from randomized trials. Clin Obstet Gynecol. 2005;48:416–29.CrossRefGoogle Scholar
  40. 40.
    Chen Q, Zhao M, Guo F, Yin YX, Xiao JP, Stone PR, Chamley LW. The reduction of circulating levels of IL-6 in pregnant women with preeclampsia by magnesium sulfate and nifedipine: in vitro evidence for potential mechanisms. Placenta. 2015;36(6):661–6.  https://doi.org/10.1016/j.placenta.2015.03.009. Epub 2015 Apr 9.CrossRefPubMedGoogle Scholar
  41. 41.
    Das M, Chaudhuri PR, Mondal BC, Mitra S, Bandyopadhyay D, Pramanik S. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian J Pharmacol. 2015;47(5):502–8.  https://doi.org/10.4103/0253-7613.165183. https://www.ncbi.nlm.nih.gov/pubmed/26600638.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of NephrologyLenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellNew YorkUSA
  2. 2.Department of NephrologyThe Mount Sinai HospitalNew YorkUSA

Personalised recommendations